4Imbert T F. Discovery of podophyllotoxins[J]. Biochimie,1998, 80(3): 207.
5Gordaliza M, Garcfa P A, del Corral J M, et al. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives [J]. Toxicon, 2004, 44(4):441.
6Hande K R. Etoposide: four decades of development of a topoisomerase Ⅱ inhibitor[J]. Eur J Cancer, 1998, 34(10):1514.
7Xiao Z, Xiao Y D, Feng J, et al. Antitumor agents. 213. Modeling of epipodophyllotoxin derivatives using variable selection k nearest neighbor QSAR method[J]. J Med Chem, 2002, 45(11):2294.
8Vanvliet D S, Tachibana Y, Bastow K F, et al. Antitumor agents. 207. Design, synthesis, and biological testing of 4beta-anilino-2- fluoro-4"-demethylpodophyllotoxin analogues as cytotoxic and antiviral agents[J]. J Med Chem, 2001, 44(9):1422.
9Zhou X M, Wang Z Q, Chang J Y, et al. Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4"-O- demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase Ⅱ[J]. J Med Chem,1991,34(12):3346.
10Cheng W H, Cao B, Shang H, et al. Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents[J]. Eur J Med Chem, 2014,85:498.
